its almost as though that anouncement was written by someone who is trying to short the stock. usually, increasing the dosage means that the safety profile of the drug is excellent. the company should have some knowlege of how the safety profile of PBT in the extension for alzhemers is looking and increasing the dosage in future trials would be a confidence boosting announcement
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $124.2M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.5¢ | 1.3¢ | $608.4K | 44.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 13554321 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 4937957 | 8 |
View Market Depth
| Last trade - 16.11pm 21/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |